Oak Street Health, Inc. (NYSE:OSH) CEO Michael T. Pykosz Sells 157,534 Shares

Oak Street Health, Inc. (NYSE:OSHGet Rating) CEO Michael T. Pykosz sold 157,534 shares of the company’s stock in a transaction on Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total value of $4,730,746.02. Following the transaction, the chief executive officer now directly owns 7,189,050 shares in the company, valued at $215,887,171.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Oak Street Health Trading Up 2.4 %

OSH stock opened at $30.29 on Friday. The company’s 50-day simple moving average is $21.54 and its 200-day simple moving average is $20.69. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 16.10. Oak Street Health, Inc. has a 52-week low of $13.29 and a 52-week high of $64.75. The firm has a market cap of $7.30 billion, a P/E ratio of -13.77 and a beta of 3.05.

Oak Street Health (NYSE:OSHGet Rating) last issued its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). The company had revenue of $513.80 million during the quarter, compared to analysts’ expectations of $506.82 million. Oak Street Health had a negative net margin of 27.11% and a negative return on equity of 716.26%. The company’s quarterly revenue was up 73.2% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.29) earnings per share. As a group, equities analysts forecast that Oak Street Health, Inc. will post -2.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of OSH. State of New Jersey Common Pension Fund D lifted its stake in Oak Street Health by 23.7% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 77,309 shares of the company’s stock valued at $2,562,000 after buying an additional 14,799 shares in the last quarter. CWM LLC purchased a new position in Oak Street Health in the 4th quarter worth approximately $851,000. C WorldWide Group Holding A S lifted its stake in Oak Street Health by 8.0% in the 4th quarter. C WorldWide Group Holding A S now owns 404,933 shares of the company’s stock worth $13,419,000 after purchasing an additional 30,000 shares in the last quarter. Toronto Dominion Bank lifted its stake in Oak Street Health by 39.6% in the 4th quarter. Toronto Dominion Bank now owns 18,999 shares of the company’s stock worth $629,000 after purchasing an additional 5,393 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its stake in Oak Street Health by 32.4% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 27,078 shares of the company’s stock worth $934,000 after purchasing an additional 6,630 shares in the last quarter. 91.42% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. SVB Leerink upped their price target on Oak Street Health from $23.00 to $32.00 and gave the stock a “market perform” rating in a research report on Thursday. Stifel Nicolaus upped their target price on Oak Street Health from $25.00 to $35.00 in a research report on Wednesday, July 27th. Barclays upped their target price on Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research report on Tuesday, April 19th. Sanford C. Bernstein began coverage on Oak Street Health in a research report on Thursday, May 26th. They issued an “outperform” rating and a $26.00 target price on the stock. Finally, UBS Group upped their target price on Oak Street Health from $26.00 to $28.00 and gave the company a “neutral” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $35.50.

Oak Street Health Company Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Insider Buying and Selling by Quarter for Oak Street Health (NYSE:OSH)

Want More Great Investing Ideas?

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.